News and Opinions - World Stem Cell Summit

Genetic cause of ALS and dementia repaired by RNA-targeting strategy developed at UF Scripps

by admin | Jan 30, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By: Stacey DeLoye – UFHealth News Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in...

Highly Mature Neurons Created

by admin | Jan 27, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Technology Netowrks Northwestern University-led researchers have created the first highly mature neurons from human induced pluripotent stem cells (iPSCs), a feat that opens new opportunities for medical research and potential transplantation therapies for...

JPM23’s Medtech Tidbits: Reporting from San Francisco

by admin | Jan 26, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Andrea Park, Conor Hale – Fierce Biotech SAN FRANCISCO—After years of stops, starts and stops again, the J.P. Morgan Healthcare Conference has returned to the city by the bay in full form. Below we’ve compiled the biggest medtech news so far,...

Scientists Identify How a Biological Pathway Leads Stem Cells to Die or Regenerate

by admin | Jan 25, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Manipulating Cell Signaling Can Possibly Ensure the Body Has a Healthy Amount of Cells By Stephanie Cajigal – Cedars Sinai A new study led by Cedars-Sinai and the University of California, San Francisco (UCSF), has determined that altering a cellular process can...

Genetics, Alzheimer’s And AI — Why 2023 Could Be The Year For Biotech Stocks

by admin | Jan 24, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Allison Gatlin – Investors.com If there’s one overarching theme that investors in biotech stocks should pay attention to in 2023, it’s “genetic medicine, genetic medicine, genetic medicine,” says Christopher Anzalone. Anzalone is...

O.K. Corral: FDA sets stage to appeal California Stem Cell Treatment Center decision

by admin | Jan 22, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Michael Druckman, Meredith Manning, and Ashley Grey – Hogan Lovells Last year, a federal court in California ruled against the U.S. Food and Drug Administration (FDA) in a matter where the government alleged that a stem cell clinic’s products should be regulated as...